YDES · NASDAQ
YD Bio (YDES) Stock Price & Fundamentals
YD Bio (YDES) closed at $328.11 on Oct 9, 2026, up 1.37% from the previous close of $323.66.
Share price, past year
1Y +27.63%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $328.11 |
| Sep 30, 2026 | $319.85 |
| Aug 31, 2026 | $308.22 |
| Jul 31, 2026 | $301.90 |
| Jun 30, 2026 | $306.76 |
| May 29, 2026 | $299.68 |
| Apr 30, 2026 | $297.00 |
| Mar 31, 2026 | $304.55 |
| Feb 27, 2026 | $273.69 |
| Jan 30, 2026 | $264.65 |
| Dec 31, 2025 | $265.19 |
| Nov 28, 2025 | $270.26 |
| Oct 31, 2025 | $271.09 |
Key statistics
- Market cap
- $23.23B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 70.8M
- Dividend yield
- —
- 52-week range
- $253.96 – $328.64
YD Bio's market cap is $23.23B, based on a share price of $328.11 and 70.8M shares outstanding as of Dec 31, 2025.
Financials
YD Bio reported revenue of $596.82K for fiscal 2025, up 16.94% from fiscal 2024.
YD Bio reported a net loss of $8.31M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $596.82K | +16.9% | −$8.31M | −1,392.6% | −$0.12 | −$8.04M |
| FY2024ended Dec 31, 2024 | $510.36K | +45.8% | −$1.41M | −276.6% | −$0.02 | −$1.30M |
| FY2023ended Dec 31, 2023 | $350.13K | — | $13.56K | 3.9% | $0.00 | −$55.95K |
Company profile
- Name
- YD Bio Ltd
- Ticker
- YDES
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Medical Laboratories
- Headquarters
- 12f., No. 3, Xingnan St., Nangang Dist., Taipei City, 115001
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0002011674
Frequently asked questions
What is YD Bio's stock price?
YD Bio (YDES) closed at $328.11 on Oct 9, 2026, up 1.37% from the previous close of $323.66.
What is YD Bio's market cap?
YD Bio's market cap is $23.23B, based on a share price of $328.11 and 70.8M shares outstanding as of Dec 31, 2025.
How much revenue does YD Bio make?
YD Bio reported revenue of $596.82K for fiscal 2025, up 16.94% from fiscal 2024.
Sources and methodology
Fundamentals come from YD Bio Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures